プレスリリース

Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June

SAN DIEGO--(BUSINESS WIRE)--May 5, 2014-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at three upcoming investment conferences.

Illumina will webcast its presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 13, 2014. The live webcast is scheduled to begin at 9:20 AM PT and will feature an overview of the company by Jay Flatley, Chief Executive Officer, followed by a question and answer session.

Illumina will also webcast its presentation at the Bank of America Merrill Lynch Global Technology Conference in San Francisco, California, on June 3, 2014. The live webcast is scheduled to begin at 4:20 PM PT and will feature an overview of the company by Francis deSouza, President, followed by a question and answer session.

Illumina will also webcast its presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 11, 2014. The live webcast is scheduled to begin at 9:20 AM PT and will feature a brief overview of the company by Jay Flatley, Chief Executive Officer, followed by a question and answer session.

The webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com

Recent Articles

英国がゲノム研究とより良いヘルスケアの新しい基準をどのように設定しているか
英国がゲノム研究とより良いヘルスケアの新しい基準をどのように設定しているか
Shriners Children’s big bet on the future of specialized pediatric care
Shriners Children’s big bet on the future of specialized pediatric care
Illumina highlights the importance of HRD testing at ESMO 2023
Video: Illumina highlights the importance of HRD testing at ESMO 2023